VolitionRX
VNRX
VNRX
34 hedge funds and large institutions have $15.1M invested in VolitionRX in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Holders
34
Holding in Top 10
1
Calls
$308K
Puts
$97K
Top Buyers
| 1 | +$1.21M | |
| 2 | +$195K | |
| 3 | +$135K | |
| 4 |
Cerity Partners
New York
|
+$92.4K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$71.7K |
Top Sellers
| 1 | -$307K | |
| 2 | -$201K | |
| 3 | -$64.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$53.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$51.3K |